tiletamine hydrochloride has been researched along with 3-(15-hydroxypentadecyl)-2,4,4-trimethyl-2-cyclohexen-1-one in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 10 (83.33) | 29.6817 |
| 2010's | 2 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Girlanda-Junges, C; Gonzalez de Aguilar, JL; Loeffler, JP; Lutz-Bucher, B; Luu, B | 1 |
| Coowar, D; Duportail, G; Girlanda-Junges, C; Gonzalez de Aguilar, JL; Loeffler, JP; Luu, B | 1 |
| Aunis, D; Bagnard, D; Bernard, F; Berton, C; Gatineau, G; Hanbali, M; Luu, B; Perraut, M | 1 |
| Gonzalez de Aguilar, JL; Jover, E; Lutz-Bucher, B; Luu, B | 1 |
| Kinoshita, Y; Kono, T; Saito, M; Satoh, I; Satoh, K; Shomori, K; Suzuki, H; Yamada, M | 1 |
| Kinoshita, Y; Saito, M; Satoh, I; Satoh, K; Shinbori, C; Suzuki, H; Watanabe, T; Yamada, M | 1 |
| Koyama, K; Monden, M; Shiomi, H; Suzuki, H; Tamura, Y; Yamada, M | 1 |
| Kazuyama, E; Okada, S; Saito, M; Satoh, K | 1 |
| Mitani, H; Saito, M; Satoh, K; Shinbori, C; Shirayama, Y | 1 |
| Hayashi, A; Kanzaki, S; Kazuyama, E; Kinoshita, Y; Okada, S; Saito, M; Satoh, I; Satoh, K | 1 |
| Bouissac, J; Dollé, P; Garwood, J; Girlanda-Jungès, C; Luu, B; Mohier, E; Paschaki, M | 1 |
| Hakozaki, A; Noma, T; Orimoto, N; Sasaki, E; Tsukihara, H; Yoshida, S | 1 |
12 other study(ies) available for tiletamine hydrochloride and 3-(15-hydroxypentadecyl)-2,4,4-trimethyl-2-cyclohexen-1-one
| Article | Year |
|---|---|
3-(15-Hydroxypentadecyl)-2,4,4-trimethyl-2-cyclohexen-1-one and its effect on neuropeptide secretion.
Topics: Animals; Arginine Vasopressin; Cyclohexanones; Fatty Alcohols; Male; Mice; Pituitary Gland | 2000 |
Neurotrophic activity of 2,4,4-trimethyl-3-(15-hydroxypentadecyl)-2-cyclohexen-1-one in cultured central nervous system neurons.
Topics: Animals; Antimetabolites; Bromodeoxyuridine; Cell Survival; Cells, Cultured; Central Nervous System; Cyclohexanones; Fatty Alcohols; Immunohistochemistry; Nerve Growth Factors; Neurites; Neurons; Rats; Structure-Activity Relationship | 2001 |
Counteraction of axonal growth inhibitory properties of Semaphorin 3A and myelin-associated proteins by a synthetic neurotrophic compound.
Topics: Animals; Animals, Newborn; Axons; Blotting, Western; Cell Count; Cells, Cultured; Cerebral Cortex; Cyclohexanones; Dendrites; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Fatty Alcohols; Immunohistochemistry; Mice; Myelin-Associated Glycoprotein; Nerve Growth Factors; Neurites; Neurons; Semaphorin-3A; Signal Transduction | 2004 |
Effect of a cyclohexenonic long-chain fatty alcohol on calcium mobilization.
Topics: Adenosine Triphosphate; Animals; Calcium; Calcium Channel Blockers; Calcium Channels; Cells, Cultured; Cyclohexanones; Fatty Alcohols; Intracellular Space; Male; Mice; Neurons, Afferent; Nifedipine; omega-Conotoxin GVIA; Serotonin; Synaptosomes | 2005 |
General administration of cyclohexenonic long-chain fatty alcohol ameliorates hyperreactivity of STZ-induced diabetic rat aorta.
Topics: Acetylcholine; Animals; Aorta; Blood Glucose; Cyclohexanones; Diabetes Mellitus, Experimental; Fatty Alcohols; In Vitro Techniques; Male; Malondialdehyde; Muscle, Smooth, Vascular; Rats; Rats, Sprague-Dawley; Reference Values; Vasoconstriction; Vasodilation | 2006 |
Ability of cyclohexenonic long-chain fatty alcohol to reverse diabetes-induced cystopathy in the rat.
Topics: Animals; Cyclohexanones; Diabetes Complications; Fatty Alcohols; Male; Rats; Rats, Sprague-Dawley; Urinary Bladder Diseases | 2007 |
Beneficial action of 2,4,4-trimethyl-3-(15-hydroxypentadecyl)-2-cyclohexen-1-one, a novel long-chain fatty alcohol, on diabetic hypoalgesia and neuropathic hyperalgesia.
Topics: Analgesics; Animals; Cyclohexanones; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Fatty Alcohols; Hyperalgesia; Male; Mice; Mice, Inbred Strains; Pain Threshold | 2006 |
Ability of cyclohexenonic long-chain fatty alcohol to ameliorate diabetes-induced cystopathy in the rat.
Topics: Animals; Cyclohexanones; Diabetes Mellitus, Experimental; Fatty Alcohols; Male; Rats; Rats, Sprague-Dawley; Urinary Bladder Diseases | 2008 |
Effects of cyclohexanonic long-chain fatty alcohol, tCFA15 on amino acids in diabetic rat brain: a preliminary study.
Topics: Amino Acids; Animals; Blood Glucose; Body Weight; Brain Chemistry; Chromatography, High Pressure Liquid; Cyclohexanones; Diabetes Mellitus, Experimental; Fatty Alcohols; Insulin; Male; Rats; Rats, Sprague-Dawley | 2008 |
Characterization of the ileal muscarinic receptor system in 70-week-old type II Goto-Kakizaki diabetic rats; effects of cyclohexenonic long-chain fatty alcohol.
Topics: Animals; Cyclohexanones; Diabetes Mellitus, Type 2; Fatty Alcohols; Gastrointestinal Motility; Gene Expression Regulation; Ileum; Male; Muscle Contraction; Polymerase Chain Reaction; Rats; Rats, Wistar; Receptor, Muscarinic M2; Receptor, Muscarinic M3; Receptors, Muscarinic; RNA, Messenger | 2009 |
tCFA15, a trimethyl cyclohexenonic long-chain fatty alcohol, affects neural stem fate and differentiation by modulating Notch1 activity.
Topics: Animals; Astrocytes; Cell Differentiation; Cyclohexanones; Fatty Alcohols; Gene Expression Regulation; Mice; Neural Stem Cells; Neurons; Receptor, Notch1; RNA, Messenger | 2013 |
TAC-302 promotes neurite outgrowth of isolated peripheral neurons and prevents bladder denervation related bladder dysfunctions following bladder outlet obstruction in rats.
Topics: Animals; Cyclohexanones; Denervation; Fatty Alcohols; Female; Neuronal Outgrowth; Neurons; Rats; Rats, Sprague-Dawley; Rats, Wistar; Urinary Bladder; Urinary Bladder Neck Obstruction; Urination | 2018 |